The FDA has even authorised a drug created with cannabidiol for that purpose (Epidiolex). Nevertheless the company only endorses it for two uncommon types of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome.Using these products and solutions in a more youthful age especially improves the chance of developing a cannabis u